Serum Pseudocholinesterase (PChE / BChE)
Hepatically synthesized glycoprotein enzyme that hydrolyzes choline esters, reflecting true liver synthetic mass.
Standard vs. Optimal Reference RangesU/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Exceeds standard commercial reference interval. Clinical correlation recommended.
5,000 - 13,000 U/L
General reference distribution across unselected commercial populations.
6,500 - 11,500 U/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Catalyzes hydrolysis of succinylcholine, mivacurium, and cocaine in plasma; synthesized solely by functional hepatocytes.
Differential Diagnosis
Elevated Levels (PChE / BChE High)
- •Nephrotic syndrome and hyperlipidemia
- •Fatty liver disease without cirrhosis
Low Levels (PChE / BChE Low)
- •Advanced cirrhosis and liver failure
- •Organophosphate/carbamate insecticide poisoning
- •Genetic atypical BCHE mutation (prolonged succinylcholine apnea)
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker panel evaluation for PChE / BChE
- Targeted imaging or functional organ assessment related to hepatic synthetic mass & toxicology
- Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Physiological Dynamics of Serum Pseudocholinesterase - The New England Journal of Medicine (2021). PMID: 33890124
- [2]PChE / BChE in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Pseudocholinesterase (PChE / BChE) into overall healthspan optimization.